Search

Search Results
Results 71 - 80 of 489 for cancer
  • AMPK Signaling Pathway
    Life Sciences - 9 Mar 2020
    Adenosine monophosphate (AMP)-activated protein kinase (AMPK) plays an important role in cellular energy homeostasis.
  • What is the Tumor Microenvironment?
    Life Sciences - 6 Feb 2020
    Tumors are often considered to be malignant cells that operate independently of their environment; however, this is not the case.
  • What are Catechins?
    Life Sciences - 3 Feb 2020
    The most commonly studied polyphenols are procyanidins, quercetin, isoflavones and catechins.
  • Pharmacology of CAR-T Cells
    Life Sciences - 26 Feb 2019
    Chimeric antigen receptor (CAR)-T cells are T cells which are genetically modified by the addition of tumor-reactive chimeric antigen receptors (CARs). The T cells are the workhorses of the immune...
  • Advances in Metabolomics Research
    Life Sciences - 23 Aug 2018
    Research in metabolomics is paving the way for advances in many fields such as plant engineering, crop protection, development of new pesticides, aquaculture—the environment as a whole. At present,...
  • What are Isogenic Cell Lines?
    Life Sciences - 1 Jul 2023
    Cell lines are formed of cells that are able to grow indefinitely. Isogenic refers to a population with essentially identical genes.
  • Lipid Peroxidation
    Life Sciences - 16 Apr 2019
    Lipid peroxidation is a metabolic process that causes oxidative deterioration of lipids by reactive oxygen species.
  • What are PARP inhibitors?
    Life Sciences - 24 Oct 2018
    PARP inhibitors are pharmaceutical drugs that can be used to treat many different forms of cancer, including ovarian and breast cancer.
  • Phosphoproteomics in Research
    Life Sciences - 23 Aug 2018
    Phosphoproteomics is an important tool in the life sciences, allowing for the study of regulatory changes with variation in conditions and time.
  • Metabolic Reprogramming and Immune Crosstalk in the Tumor Microenvironment
    Life Sciences - 22 Dec 2025
    Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into improving cancer immunotherapy.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback